---
figid: PMC9688074__cells-11-03642-g004
figtitle: Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory
  Diseases
organisms:
- Mus musculus
- Rattus norvegicus
- Hepatitis B virus
- adeno-associated virus 2
- Staphylococcus aureus PM1
- Staphylococcus aureus
- Streptococcus uberis
- Escherichia coli 27A
- Escherichia coli
- Homo sapiens
- Canis lupus familiaris
- Bos taurus
- Oryctolagus cuniculus
organisms_ner:
- Rattus norvegicus
- Canis lupus familiaris
- Oryctolagus cuniculus
- Bos taurus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9688074
filename: cells-11-03642-g004.jpg
figlink: /pmc/articles/PMC9688074/figure/cells-11-03642-f004/
number: F4
caption: Mechanism of lncRNAs in acute renal injury. LncRNA CCAT1 inhibits the activation
  of NF-κB via regulating the miR-155/SIRT1 axis. Paclitaxel binds to MD-2 to block
  MD-2/TLR4 association, resulting in the suppression of NF-κB activation. In addition,
  paclitaxel can protect against AKI via the regulation of lncRNA MALAT1/miR-370-3p/HMGB1
  axis. Knockdown of lncRNA MALAT1 inhibits the activation of NF-κB by targeting miR-146a.
  Curcumin attenuates the activation of the JNK/NF-κB signaling pathway by inhibiting
  lncRNA PVT1, thereby alleviating the inflammatory response in AKI.
papertitle: Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response
  and Inflammatory Diseases.
reftext: Fen Feng, et al. Cells. 2022 Nov;11(22):3642.
year: '2022'
doi: 10.3390/cells11223642
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: lncRNA | immunity | inflammatory diseases | gene expression | regulatory
  mechanism
automl_pathway: 0.933452
figid_alias: PMC9688074__F4
figtype: Figure
redirect_from: /figures/PMC9688074__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9688074__cells-11-03642-g004.html
  '@type': Dataset
  description: Mechanism of lncRNAs in acute renal injury. LncRNA CCAT1 inhibits the
    activation of NF-κB via regulating the miR-155/SIRT1 axis. Paclitaxel binds to
    MD-2 to block MD-2/TLR4 association, resulting in the suppression of NF-κB activation.
    In addition, paclitaxel can protect against AKI via the regulation of lncRNA MALAT1/miR-370-3p/HMGB1
    axis. Knockdown of lncRNA MALAT1 inhibits the activation of NF-κB by targeting
    miR-146a. Curcumin attenuates the activation of the JNK/NF-κB signaling pathway
    by inhibiting lncRNA PVT1, thereby alleviating the inflammatory response in AKI.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ly96
  - Mir146a
  - Tlr4
  - Nfkb1
  - Il6
  - Il1b
  - Tnf
  - Mapk8
  - Syt1
  - Mir155
  - MIR146A
  - TLR4
  - IL6
  - IL1B
  - TNF
  - JUN
  - MIR155
  - LY96
  - NFKB1
  - MAPK8
  - MAPK9
  - MAPK10
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - Mir146
  - Rela
  - Gorasp1
  - Jun
  - mir146a
  - il6
  - il1b
  - tnfb
  - mapk8b
  - rela
  - jun
  - mir155
---
